About

 Background

  • General Probiotics (GP) is an American biotechnology company that discovers, develops and commercializes medicines for infectious diseases.
  • GP engineers are world leaders in probiotics, with the expertise to boost the natural capacity of probiotics to exterminate pathogens. Our advanced probiotics eliminate pathogens more effectively and reliably than any currently marketed probiotic. Our technology is scientifically proven and is covered by numerous patent applications.
  • GP has been awarded Phase I and Phase II Small Business Innovative Research grants, in order to pursue an unparalleled R&D program and commercialize new antimicrobials.

Products

  • GP develops new antimicrobials. Our products eliminate pathogens in food-producing animals. Experiments have demonstrated that our products can eliminate 97% of foodborne pathogens in pre-harvest poultry.
  • With patented technologies, we develop products to fight bacterial infections, secure food production, and eliminate the overuse of antibiotics in livestock production.

Market

  • Chicken producers need antimicrobial technologies to eliminate pathogenic microbes in chicken. They need antimicrobial technologies to produce healthy chicken flocks and to eliminate the risk of contaminated meat they sell. They need antimicrobial technologies to defend product brand, meet USDA inspection standards, meet FDA food safety standards, and to mitigate recall and litigation risk.
  • We develop an antimicrobial technology that eliminates pathogens in chickens. Our products will help chicken producers produce and distribute whole chickens and chicken parts that are not contaminated with salmonella, clostridia or campylobacter. Our products will help chicken producers defend and maintain the integrity of their brand. Our products will lower the risk of foodborne infection outbreaks, lower the risk of chicken product recalls, and lower the risk of litigation against chicken producers in the event of an outbreak. Our product will help ensure the supply of safe food to consumers.

Status 

nsfGeneral Probiotics has received Small Business Innovative Research grants from the US National Science Foundation.

General Probiotics is headquartered at 1000 Westgate Dr, Ste 122, St. Paul, MN 55114

General Probiotics is licensing technology from the University of Minnesota and is seeking strategic partners and early-stage investors.